Shape memory polymer technology in peripheral vascular embolization.
| Autor: | Holden A; Department of Radiology, Auckland City Hospital, Auckland, New Zealand., Hill AA; Department of Vascular Services, Auckland City Hospital, Auckland, New Zealand., Buckley BT; Department of Radiology, Auckland City Hospital, Auckland, New Zealand. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Vascular [Vascular] 2024 Oct; Vol. 32 (5), pp. 1137-1142. Date of Electronic Publication: 2023 May 22. |
| DOI: | 10.1177/17085381231177851 |
| Abstrakt: | Objectives: Porous, radiolucent, shape memory polymer is a new technology available in discrete peripheral vascular embolization devices. Shape memory polymers can exist in two stable shapes; crimped for catheter delivery and expanded for vessel embolization. The expanded shape memory polymer in these new devices is hemostatic, and the porous polymeric scaffold has been shown to support tissue ingrowth and eventually bioabsorbs in preclinical animal studies. This report describes clinical experience with this novel material in vascular plug devices. Methods: a prospective, single-arm, safety study at a single center in New Zealand with longer term follow-up via retrospective imaging review. The study device was a pushable shape memory polymer vascular plug with a distal nitinol anchor coil and a proximal radiopaque marker. Results: Ten male patients were each implanted with a single shape memory polymer vascular plug. Three inferior mesenteric arteries and an accessory renal artery were embolized during endovascular aneurysm repair. An internal iliac artery was treated prior to the open surgical repair of aorto-iliac aneurysms. An internal iliac artery and a subclavian artery were embolized to treat/prophylactically address potential endoleaks. A profunda branch was embolized prior to tumor resection, and two testicular veins were embolized to treat varicoceles. Acute technical success of target vessel embolization was achieved in all implantation cases. Patients were followed for 30 days as part of the study, and no serious adverse events with a relationship to the study device occurred. No recurrent clinical symptoms attributable to treated vessel embolization or recanalization were documented. There was no evidence of recanalization on retrospective review of follow-up imaging through a mean of 22.2 months (range, <1-44 months) post-procedure. Conclusions: Shape memory polymer vascular embolization devices were safe and effective over the follow-up period of this small safety study. Further experience and longer term follow-up will assess further applicability. Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Andrew Holden is a consultant to Shape Memory Medical. All other authors have no relevant conflicts of interest to declare. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|